Acute Cheilitis with Oseltamivir

Published On: 11 Apr, 2024 1:55 PM | Updated On: 11 Apr, 2024 2:20 PM

Acute Cheilitis with Oseltamivir

A report describes a case of an 11-year-old girl who presented with lower lip cheilitis and stomatitis for a day. There was no history of any such previous episodes, and none of the other body parts were affected. She was taking oseltamivir capsules (75 mg twice daily) 2 days before the swelling began. The patient had visited a primary care doctor with a bout of seasonal influenza with fever, cough, and arthralgia, which was relieved with Oseltamivir. Concomitantly, she also took an expectorant (dextromethorphan) and an anti-inflammatory drug (tiaramide hydrochloride) for two days. She has a history of expectorant and anti-inflammatory drug consumption many times before that did not cause any problems. 

Examination showed the patient to be febrile (38.0°C), with a white swollen lip, ulcerated labia, and bilateral cervical lymphadenopathy. Other physical examinations were unremarkable.

Laboratory investigations showed leukopenia, neutrophil granulocytes, elevated C-reactive protein, and no vitamin deficiencies. Comprehensive respiratory virus testing or antibody titer studies showed no significant results. 

She was advised to stop Oseltamivir and treated with an expectorant and anti-inflammatory drug, which resolved her symptoms and signs within 36 hours. There was no recurrence of symptoms till a year later. 

Yokoyama K, Mamada M. Acute Cheilitis Associated with Oseltamivir after Influenzae A Infection. Case Reports in Pediatrics. 2023;2023. https://doi.org/10.1155/2023/8618245

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks